Trials that use: Multiplicity adjustment
New to this method? Read the tutorial →
20,317 results
- Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia: Complete Statistical AnalysisIndependent statistical analysis of Safety And Tolerability Of Multiple Doses Of PF-04950615 (RN316) In Subjects With Hypercholesterolemia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003): Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Oral Polyethylene Glycol (PEG 3350) Solution in Participants With Constipation (MK-8114-003): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety and Tolerability of PF-06649751 in Parkinson’s Disease Patients With Motor Fluctuations: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of PF-06649751 in Parkinson's Disease Patients With Motor Fluctuations: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov…
- Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301): Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of POD-DHE (INP104) in Migraine (STOP 301): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03557333).
- Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Preservative-free Polyhexamethylene Biguanide (PHMB) Ophthalmic Solution in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Tolerability of Seroguard Use: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Seroguard Use: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03640559).
- Safety and Tolerability of Soy Fiber: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Soy Fiber: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04499482).
- Safety and Tolerability of Vortioxetine (LuAA21004) – Open Label Extension Study: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability of Vortioxetine (LuAA21004) - Open Label Extension Study: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia: primary endpoint…
- Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of Adhansia XR® Extended-Release Capsules in Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of MDV3100 in Combination With Docetaxel in Men With Advanced Prostate Cancer: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of MEDI0382 in Japanese Preobese or Obese Subjects With Type 2 Diabetes: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety and Tolerability Study of N6022 in Healthy Subjects: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of N6022 in Healthy Subjects: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01147406).
- Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF): Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of Pirfenidone in Combination With Nintedanib in Participants With Idiopathic Pulmonary Fibrosis (IPF): primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.: Complete Statistical AnalysisIndependent statistical analysis of Safety And Tolerability Study Of RN564 In Women With Osteopenia And Healthy Men.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy: Complete Statistical AnalysisIndependent statistical analysis of Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration,…
- Safety and Tolerability Study of SHP626 in Overweight and Obese Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Study of SHP626 in Overweight and Obese Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine: Complete Statistical AnalysisIndependent statistical analysis of Safety and Tolerability Trial of Switching From Ropinirole to Rotigotine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00593606).
- Safety Evaluation of a Q-fever Vaccine, NDBR 105: Complete Statistical AnalysisIndependent statistical analysis of Safety Evaluation of a Q-fever Vaccine, NDBR 105: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT00584454).
- Safety Evaluation of Aline HA, an Implanted Cross-Linked HA Device: Complete Statistical AnalysisIndependent statistical analysis of Safety Evaluation of Aline HA, an Implanted Cross-Linked HA Device: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT01708213).
- Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy: Complete Statistical AnalysisIndependent statistical analysis of Safety Evaluation of an Experimental Treatment, Intradermal Human Fcγ1-Fel d1 Fusion Protein (GFD), for Cat Allergy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty: Complete Statistical AnalysisIndependent statistical analysis of Safety Extension Study Of Leuprolide Acetate (Lupron Depot) In The Treatment Of Central Precocious Puberty: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis: Complete Statistical AnalysisIndependent statistical analysis of Safety Extension Study Of Tanezumab When Administered By Subcutaneous Injection To Patients With Osteoarthritis: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD: Complete Statistical AnalysisIndependent statistical analysis of Safety of 16.5 mg (3.3%) CGC-11047 Once Every 2 Weeks vs. Once Every 4 Weeks in Patients With CNV Due to AMD: primary endpoint results, effect estimate with…
- Safety of 4CMenB Exposure During Pregnancy: Complete Statistical AnalysisIndependent statistical analysis of Safety of 4CMenB Exposure During Pregnancy: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02640677).
- Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals’ Boostrix™ Vaccine in Healthy Vietnamese Children: Complete Statistical AnalysisIndependent statistical analysis of Safety of a Booster Dose of GlaxoSmithKline (GSK) Biologicals' Boostrix™ Vaccine in Healthy Vietnamese Children: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity in a Subset of Subjects With Underlying Medical Conditions: Complete Statistical AnalysisIndependent statistical analysis of Safety of a Influenza Vaccine Produced Either in Mammalian Cell Culture or in Embryonated Hen Eggs in Adults and Elderly With and Without Underlying Medical Conditions, and Immunogenicity…
- Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam: Complete Statistical AnalysisIndependent statistical analysis of Safety of a Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine in Healthy Subjects in Vietnam: primary endpoint results, effect estimate with confidence interval,…
- Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth: Complete Statistical AnalysisIndependent statistical analysis of Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Safety of and Immune Response to an H1N1 Influenza Vaccine in HIV Infected Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety,…
- Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents: Complete Statistical AnalysisIndependent statistical analysis of Safety of and Immune Response to Dolutegravir in HIV-1 Infected Infants, Children, and Adolescents: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6: Complete Statistical AnalysisIndependent statistical analysis of Safety of Artificial Pancreas Therapy in Preschoolers, Age 2-6: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT04084171).
- Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to <6 Years With AR: Complete Statistical AnalysisIndependent statistical analysis of Safety of Astepro 0.15% Nasal Spray and Astepro 0.1% Nasal Spray in Children Ages >6 Months to
- Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase: Complete Statistical AnalysisIndependent statistical analysis of Safety of Buprenorphine Transdermal Patch (BTDS) in Osteoarthritis Pain: a 52-Week Extension Phase: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on…
- Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement: Complete Statistical AnalysisIndependent statistical analysis of Safety of Buprenorphine Transdermal System (BTDS) in Subjects With Acute Postoperative Pain After Total Knee Replacement: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and…
- Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.: Complete Statistical AnalysisIndependent statistical analysis of Safety of DTaP-IPV-Hep B-PRP~T Combined Vaccine Compared to Tritanrix-HepB/Hib™ and OPV Given at Age 2, 4, and 6 Months.: primary endpoint results, effect estimate with confidence interval, sample-size…
- Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.: Complete Statistical AnalysisIndependent statistical analysis of Safety of Endoscopic Resection of Large Colorectal Polyps: A Randomized Trial.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results…
- Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection: Complete Statistical AnalysisIndependent statistical analysis of Safety of EVG+RTV Administered With Other Antiretroviral Agents for the Treatment of HIV-1 Infection: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma: Complete Statistical AnalysisIndependent statistical analysis of Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based…
- Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes: Complete Statistical AnalysisIndependent statistical analysis of Safety of Insulin Detemir Produced by a New Process as Measured by Antibody Formation in Subjects With Type 1 Diabetes: primary endpoint results, effect estimate with confidence interval,…
- Safety of Intravenous Apramycin in Adults: Complete Statistical AnalysisIndependent statistical analysis of Safety of Intravenous Apramycin in Adults: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05590728).
- Safety of Intravenous Neridronic Acid in CRPS: Complete Statistical AnalysisIndependent statistical analysis of Safety of Intravenous Neridronic Acid in CRPS: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT02972359).
- Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.: Complete Statistical AnalysisIndependent statistical analysis of Safety of KAE609 in Adults With Uncomplicated Plasmodium Falciparum Malaria.: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03334747).
- Safety of Nerivio in Pregnant Women With Migraine: Complete Statistical AnalysisIndependent statistical analysis of Safety of Nerivio in Pregnant Women With Migraine: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT05464069).
- Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea: Complete Statistical AnalysisIndependent statistical analysis of Safety of One Dose of Meningococcal ACWY Conjugate Vaccine in Subjects From 2 Months to 55 Years of Age in the Republic of South Korea: primary endpoint results,…
- Safety of Optimal PEEP in NSICU Patients: Complete Statistical AnalysisIndependent statistical analysis of Safety of Optimal PEEP in NSICU Patients: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03862027).
- Safety of RIV4 Versus IIV4 in Pregnant Women: Complete Statistical AnalysisIndependent statistical analysis of Safety of RIV4 Versus IIV4 in Pregnant Women: primary endpoint results, effect estimate with confidence interval, sample-size planning illustration, and safety, based on ClinicalTrials.gov results (NCT03969641).